Clinical Trial Visit Schedule: What to Check

Every trial runs on a protocol, which the National Cancer Institute describes as being like a recipe for the study. The protocol sets out the purpose, who can join, which medical tests are done and how often, the treatment with its dose and route, and what information gets collected. Buried in it is a grid that decides your next several months: the visit calendar.

Ask for that calendar on paper before you consent, not after. Study teams have it. It is often labeled a schedule of events or schedule of assessments, and it lists each visit down one side and each procedure across the top. If a coordinator can only describe the schedule out loud, ask them to print it. You cannot plan work, childcare, or driving around a memory of a conversation.

Most cancer drug trials count time in cycles. A cycle is a stretch of treatment followed by a rest period that lets healthy cells recover. NCI gives one example: treatment every day for a week, then three weeks off, with those four weeks making up one cycle. Trials keep that structure and then add research visits on top.

So the first two questions are simple. How many days are in one cycle? Which days inside the cycle need me in the building? A trial that looks like "one visit a month" on the phone can turn out to need day 1, day 8, and day 15 of every cycle.

NCI is direct about this. Taking part may mean extra doctor visits you would not have with standard treatment, so the team can watch closely for side effects. That is the trade. Closer monitoring is a real benefit, and it is also a real demand on your calendar.

Early-phase trials demand the most. A phase 1 trial usually enrolls 15 to 30 people and exists to find a safe dose and learn how the treatment affects the body. That work needs frequent checks, and the first cycle is often the heaviest. Ask directly whether the first cycle is busier than later ones, and by how much.

When you get the calendar, mark each visit as one of four types. The mix tells you far more than the total count.

• Treatment visits, where you actually receive the study drug. These are usually the least flexible.
• Lab-only visits, often short, sometimes possible at a local lab.
• Imaging visits, which follow their own fixed timetable and can run long.
• Safety and follow-up visits, including the end-of-treatment visit and later check-ins.

Then ask which of these have a window. Some visits must happen on an exact day. Others allow a few days either side. Knowing which is which is the difference between rescheduling a holiday and losing your place in the study.

A calendar showing eight visits can hide 60 hours. For each visit type, ask four things: how long does it take from arrival to discharge, do I need to fast, do I need a driver afterwards, and can a caregiver stay with me?

Some visits include repeated blood draws over several hours to measure how the drug moves through the body. Those days are long even though nothing dramatic happens. Others are 20 minutes. Averaging them tells you nothing useful, so get the real numbers per visit type.

Before any of this, there is screening. The study team reviews your medical history and runs tests to confirm you qualify. Some tests get repeated even if you had them recently, because the protocol requires results from a specific window. Screening can take days to weeks, and people can be ruled out at this stage.

Ask how many screening visits there are, how long results take, and what happens to your standard care while you wait.

Costs split in two. Patient care costs are things you would have had anyway, such as clinic visits, hospital stays, standard drugs, scans, and lab work, and insurance often covers them. Research costs are trial-specific, such as the study drug and research-only tests, and the sponsor often covers those.

The visit schedule mostly drives a third category that neither side automatically pays: travel, lodging, meals, parking, and child or elder care. Some trials help with these, and some do not. Ask before you consent, ask whether help comes as reimbursement or upfront payment, and ask how long reimbursement takes.

Coordinators hear "I can manage" far too often. If you cannot drive after sedation, cannot take a Thursday off, or cannot afford a 90-minute trip twice a week, say so during consent. Teams can sometimes shift a visit day, arrange a local lab draw, or connect you with travel support. They cannot fix a problem they never hear about.

Remember that you can leave a study at any time, even after signing. If the schedule turns out to be unworkable, your doctor will discuss other treatment options with you.

Call your study team straight away, day or night, if you have a fever of 100.4°F (38°C) or higher while you are receiving a study treatment. CDC treats fever during chemotherapy as a medical emergency, because it may be the only sign of an infection that turns serious within hours. If nobody picks up quickly, go to an emergency department and tell the staff which trial you are on. Either way, let the study team know afterwards, since it has to be recorded.

Also go straight to emergency care for any symptom your consent form flags as an emergency, for a reaction with wheezing, throat tightness or faintness after a dose, or for sudden chest pain, breathlessness or confusion.

• You will miss a treatment visit, or you already missed one. Call the same day, not at the next visit.
• You have any other symptom your consent form lists as urgent.
• You cannot take the study drug as directed, including doses you vomited or forgot.
• A ride, a caregiver, or a lodging plan falls through before a required visit.
• You are considering stopping, so the team can arrange proper safety follow-up.

• May I have the schedule of events on paper, covering screening through follow-up?
• How long is one cycle, and which days need me on site?
• Which visits have a date window, and how wide is it?
• How many hours should I block for each type of visit?
• Which labs or scans could be done closer to home?
• What travel, parking, or lodging help does this study offer?
• What happens if I miss a visit or need to reschedule?
• After treatment ends, how long does follow-up continue, and in what form?

• National Cancer Institute — Taking Part in Cancer Treatment Research Studies.
• National Cancer Institute — What to Expect During a Clinical Trial.
• National Cancer Institute — Chemotherapy to Treat Cancer.
• National Cancer Institute — Who Pays for Clinical Trials?.
• Centers for Disease Control and Prevention — Fever and Cancer Treatment.

Helpful next pages include Clinical Trial Scan Schedule: What to Ask, How Are Clinical Trial Costs and Insurance Handled?, Decentralized Clinical Trials: What Patients Should Ask, Getting to Cancer Treatment: Help With Transportation, Comparing a Clinical Trial to Standard Treatment, Stopping a Clinical Trial: What to Ask.